Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...
NetworkNewsWire Editorial Coverage : Alzheimer's disease (“AD”) has become a focal point in the Pharmaceutical industry as recent drugs such as Leqembi and Kisunla have received U.S. Food and Drug ...